Description
- The Quadruple Marker Test is a blood test that provides valuable pregnancy information. It can help in determining a baby's chances of developing Edward's syndrome (trisomy 18), Down syndrome, or neural tube defects. The test estimates the risk of a serious problem. It does not provide a diagnosis of the problem. The Quadruple Marker Test shows if a woman is more likely or less likely
The Quadruple Marker Test is a blood test that provides valuable pregnancy information. It can help in determining a baby's chances of developing Edward's syndrome (trisomy 18), Down syndrome, or neural tube defects. The test estimates the risk of a serious problem. It does not provide a diagnosis of the problem. The Quadruple Marker Test shows if a woman is more likely or less likely to have a baby with a birth defect.
Overview of the Quadruple Marker Test
A Quadruple Marker Test, also known as a quad screen test, is a blood test performed during the second trimester (15-20 weeks) of pregnancy to detect chromosomal abnormalities and birth problems in the unborn baby. The Quadruple Marker Test is used to measure the levels of various substances in the women's blood. Those substances are mentioned below:
Human chorionic gonadotropin (hCG), a placental hormone.
Alpha-fetoprotein (AFP), a protein that is released by the growing baby.
Inhibin A, a hormone secreted by the placenta.
Unconjugated Estriol (UE), a hormone secreted by the liver and placenta of the baby.
The Quadruple Marker Test is safe for the baby and helps in the identification of any chromosomal, genetic defects, or growing abnormalities in the unborn baby including Down syndrome, spinal cord, brain, or other neurological issues.
Track and manage your health better with SAMPLE REPORT
Description
- The Quadruple Marker Test is a blood test that provides valuable pregnancy information. It can help in determining a baby's chances of developing Edward's syndrome (trisomy 18), Down syndrome, or neural tube defects. The test estimates the risk of a serious problem. It does not provide a diagnosis of the problem. The Quadruple Marker Test shows if a woman is more likely or less likely
The Quadruple Marker Test is a blood test that provides valuable pregnancy information. It can help in determining a baby's chances of developing Edward's syndrome (trisomy 18), Down syndrome, or neural tube defects. The test estimates the risk of a serious problem. It does not provide a diagnosis of the problem. The Quadruple Marker Test shows if a woman is more likely or less likely to have a baby with a birth defect.
Overview of the Quadruple Marker Test
A Quadruple Marker Test, also known as a quad screen test, is a blood test performed during the second trimester (15-20 weeks) of pregnancy to detect chromosomal abnormalities and birth problems in the unborn baby. The Quadruple Marker Test is used to measure the levels of various substances in the women's blood. Those substances are mentioned below:
Human chorionic gonadotropin (hCG), a placental hormone.
Alpha-fetoprotein (AFP), a protein that is released by the growing baby.
Inhibin A, a hormone secreted by the placenta.
Unconjugated Estriol (UE), a hormone secreted by the liver and placenta of the baby.
The Quadruple Marker Test is safe for the baby and helps in the identification of any chromosomal, genetic defects, or growing abnormalities in the unborn baby including Down syndrome, spinal cord, brain, or other neurological issues.